Astellas Pharma Inc. Stock

Stocks

4503

JP3942400007

Pharmaceuticals

OTC Markets Traded
Market Closed - 04:30:00 31/08/26 pm AEST 5-day change 1st Jan Change
2,371.50 JPY +0.04% Intraday chart for Astellas Pharma Inc. -1.45% +13.31%

Valuation : Astellas Pharma Inc.

Market Cap 4,250B 26.57B 22.89B 21.47B 19.6B 36.91B 2,539B 37.03B 255B 99.37B 1,282B 99.75B 97.58B P/E 2027 *
11.5x
P/E 2028 * 12.2x
Enterprise Value 4,191B 26.2B 22.58B 21.17B 19.32B 36.4B 2,504B 36.52B 251B 97.98B 1,264B 98.36B 96.22B EV / Sales 2027 *
1.8x
EV / Sales 2028 * 1.75x
Free-Float
98.88%
Yield 2027 *
3.39%
Yield 2028 * 3.5%
1 day+0.04%
1 week-1.45%
Current month+7.70%
1 month+7.70%
3 months+9.08%
6 months-1.17%
Current year+13.31%
1 week 2,330.5
Extreme 2330.5
2,455
1 month 2,125
Extreme 2125
2,455
Current year 2,041
Extreme 2041
2,717
1 year 1,557.5
Extreme 1557.5
2,717
3 years 1,243.5
Extreme 1243.5
2,717
5 years 1,243.5
Extreme 1243.5
2,717
10 years 1,243.5
Extreme 1243.5
2,717
Manager TitleAgeSince
Chief Executive Officer 63 10/02/2023
Director of Finance/CFO 54 01/11/2023
Compliance Officer - 01/04/2025
Director TitleAgeSince
Chairman 66 10/02/2023
Director/Board Member 63 01/06/2019
Director/Board Member 58 01/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.04%-1.45%+44.30%+7.09% 26.57B
-0.13%-6.44%+60.34%+114.35% 1,047B
+0.85%-0.81%+51.29%+63.71% 646B
-1.03%-3.58%+21.43%+72.25% 451B
-1.07%-4.18%+36.40%+36.34% 355B
-0.45%-2.78%+21.37%+37.99% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-1.05%-1.57%+50.30%+67.68% 234B
-1.40%-2.71%-20.25%-54.29% 203B
-2.14%-0.30%+28.95%+87.59% 181B
Average -0.47%-2.48%+29.56%+44.42% 368.58B
Weighted average by Cap. -0.38%-3.44%+37.86%+65.43%

Financials

2027 *2028 *
Net sales 2,329B 14.56B 12.55B 11.76B 10.74B 20.23B 1,392B 20.29B 140B 54.45B 702B 54.66B 53.48B 2,155B 13.47B 11.61B 10.89B 9.94B 18.72B 1,288B 18.78B 129B 50.39B 650B 50.59B 49.49B
Net income 356B 2.22B 1.92B 1.8B 1.64B 3.09B 213B 3.1B 21.32B 8.32B 107B 8.35B 8.17B 333B 2.08B 1.79B 1.68B 1.53B 2.89B 199B 2.9B 19.93B 7.77B 100B 7.81B 7.64B
Net Debt -59.18B -370M -319M -299M -273M -514M -35.36B -516M -3.55B -1.38B -17.85B -1.39B -1.36B -481B -3B -2.59B -2.43B -2.22B -4.17B -287B -4.19B -28.8B -11.24B -145B -11.28B -11.04B
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
31/08/26 JPY 2,371.50 +0.04% 15,498,500
28/08/26 JPY 2,370.50 -0.86% 6,036,800
27/08/26 JPY 2,391.00 -1.22% 3,828,800
26/08/26 JPY 2,420.50 +0.23% 6,620,200
25/08/26 JPY 2,415.00 +0.35% 4,225,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,370.50JPY
Average target price
2,512.14JPY
Spread / Average Target
+5.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4503 Stock